Skip to main content
  • Contact
  • Glossary
  • Subscribe
  • Search

PATH's Malaria Vaccine Initiative

Accelerating Malaria Vaccine Development

  • Malaria vaccines & biologics
    • Need for vaccines
      • Malaria vaccine roadmap
      • Preferred product characteristics
    • Malaria parasite life cycle
  • R&D
    • First-generation vaccines
    • Next-generation vaccines
      • Pre-erythrocytic vaccine candidates
      • Blood-stage vaccine candidates
      • Transmission-blocking vaccine candidates
      • Combination vaccine candidates
    • Monoclonal antibodies
  • RTS,S
    • Piloting RTS,S
      • Cost of delivering RTS,S
      • Public health impact and cost-effectiveness
      • Qualitative study on vaccine use
      • Case control studies
    • Clinical trial history of RTS,S
      • RTS,S use in seasonal settings
    • Expanded use of RTS,S
  • Access
    • Preparing for malaria vaccine decisions
      • Global policy and regulatory pathways
      • Decision-making framework
        • The decision-making framework for malaria vaccines
        • Economic analysis
        • Public health impact analysis
        • Sociocultural research
    • Financing
  • Resources
    • Search all resources
    • Fact sheets
    • Journal articles
    • Publications
    • Videos
    • Reports
    • Past projects
  • News
    • Press releases
    • Perspectives
  • About us
    • Donors
    • Contact us
  • Work with us
    • RFPs
    • Advocacy
      • Malaria Vaccine Advocacy Fellowship
      • Tools for advocates
    • Propose a project
  • Malaria vaccines & biologics
    • Need for vaccines
      • Malaria vaccine roadmap
      • Preferred product characteristics
    • Malaria parasite life cycle
  • R&D
    • First-generation vaccines
    • Next-generation vaccines
      • Pre-erythrocytic vaccine candidates
      • Blood-stage vaccine candidates
      • Transmission-blocking vaccine candidates
      • Combination vaccine candidates
    • Monoclonal antibodies
  • RTS,S
    • Piloting RTS,S
      • Cost of delivering RTS,S
      • Public health impact and cost-effectiveness
      • Qualitative study on vaccine use
      • Case control studies
    • Clinical trial history of RTS,S
      • RTS,S use in seasonal settings
    • Expanded use of RTS,S
  • Access
    • Preparing for malaria vaccine decisions
      • Global policy and regulatory pathways
      • Decision-making framework
    • Financing
  • Resources
    • Search all resources
    • Fact sheets
    • Journal articles
    • Publications
    • Videos
    • Reports
    • Past projects
  • News
    • Press releases
    • Perspectives
  • About us
    • Donors
    • Contact us
  • Work with us
    • RFPs
    • Advocacy
      • Malaria Vaccine Advocacy Fellowship
      • Tools for advocates
    • Propose a project
  • Home
  • Resources
  • Resources

Resources

Displaying 33 - 40 of 43

International Reference Center for Malaria Serology

Published 26 September 2015
Fact sheet

Growth Inhibition Assay (GIA) & Standard Membrane Feeding Assay (SMFA) Reference Center

Published 27 September 2015
Fact sheet

Transmission-blocking vaccines (TBVs) against malaria

Published 20 April 2016
Fact sheet

PATH's Malaria Vaccine Initiative

Published 13 April 2018
Fact sheet

Researching and addressing community perceptions of vaccines and malaria

Published 24 April 2017
Fact sheet

Preparing for malaria vaccines in Africa: A tool for malaria vaccine decision-making

Published 24 April 2017
Fact sheet

MVI’s strategy for developing next-generation malaria vaccines

Published 3 October 2015
Fact sheet

Malaria vaccine development update

Published 4 October 2015
Fact sheet

Pages

  • « first
  • ‹ previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • next ›
  • last »

PATH Washington DC

455 Massachusetts Avenue NW, Suite 1000

Washington, DC 20001 | USA 

Tel: 202.822.0033

Fax: 202.457.1466

Email: mvi_info [at] path.org

PATH Headquarters

2201 Westlake Avenue, Suite 200

Seattle, WA 98121 | USA 

Tel: 206.285.3500

Fax: 206.285.6619

Email: info [at] path.org

Website: www.path.org

Follow us

Mail
Twitter
  • Privacy policy
  • Copyright policy
  • Terms of use
© 2023 PATH
Website by Manta Ray Media